Auriclosene | 846056-87-9

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 有机磺酸及其衍生物
• 英文名称: Auriclosene
• 英文别名: 2-(dichloroamino)-2-methylpropane-1-sulfonic acid
• CAS: 846056-87-9
• 化学式: C₄H₉Cl₂NO₃S
• 分子量: 222.09
• InChiKey: QYNRGGHZWCUZLK-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -1.9
• 重原子数：
  11
• 可旋转键数：
  2
• 环数：
  0.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  66
• 氢给体数：
  1
• 氢受体数：
  4

反应信息

• 作为产物：
  描述：

  2-amino-2-methylpropanesulfonic acid 以100的产率得到Auriclosene
  参考文献：
  名称：

  Bioorg. Med. Chem. Lett. 2009, 19, 1110-1114

  摘要：

  DOI：

文献信息

• Di-isopropyl-phosphinoyl-alkanes as topical agents for the treatment of sensory discomfort
  申请人：Wei Edward T.

  公开号：US20150164924A1

  公开（公告）日：2015-06-18

  The present discovery pertains generally to the field of therapeutic compounds. More specifically the present discovery pertains to certain di-isopropyl-phosphinoyl-alkanes as described herein, DIPA-1-5, DIPA-1-6, DIPA-1-7, DIPA-1-8, and DIPA-1-9, collectively referred to herein as “DIPA compounds”, that are useful, for example, in the treatment of disorders (e.g., diseases) including: sensory discomfort (e.g., caused by irritation, itch, or pain); a skin dysesthesia; dermatitis; ocular pain and discomfort; heat discomfort; heat stress; flushing and/or night sweats (vasomotor symptoms); post-operative hypothermia; post-anaesthetic shivering; fatigue; tiredness; depression; cognitive dysfunction; and to enhance cognitive function. The applicant has found that localized delivery of DIPA compounds to the upper eyelid and/or facial skin has an alerting and enhancement effect on behavior and can be used to give a cosmetic refreshing look, to mental alertness, to reduce fatigue, and to improve work output. The present discovery also pertains to pharmaceutical compositions comprising such compounds, and the use of such compounds and compositions, for example, in therapy, in diagnosis of neuropathic pain, and in study of TRPM8 function.

  本发现通常涉及治疗化合物领域。更具体地，本发现涉及如下所述的某些二异丙基磷酰基烷烃，即DIPA-1-5、DIPA-1-6、DIPA-1-7、DIPA-1-8和DIPA-1-9，以下统称为“DIPA化合物”，这些化合物在治疗包括但不限于感觉不适（例如由刺激、瘙痒或疼痛引起）、皮肤感觉异常、皮炎、眼部疼痛和不适、热感不适、热应激、潮红和/或盗汗（血管运动症状）、术后低体温、麻醉后颤抖、疲劳、疲倦、抑郁、认知功能障碍以及增强认知功能等疾病（例如疾病）的治疗中具有用途。申请人发现将DIPA化合物局部传递至上眼睑和/或面部皮肤对行为具有警觉和增强效果，并可用于给予一种化妆上的焕然一新的外观，提高精神警觉度，减轻疲劳，并提高工作产出。本发现还涉及包含此类化合物的药物组合物，以及此类化合物和组合物的用途，例如在治疗、神经病痛诊断和TRPM8功能研究中的应用。
• [EN] METHODS AND COMPOSITIONS FOR THE TREATMENT OF PAIN<br/>[FR] MÉTHODES ET COMPOSITIONS POUR LE TRAITEMENT DE LA DOULEUR
  申请人：HELLER ADAM

  公开号：WO2010017405A1

  公开（公告）日：2010-02-11

  The invention features methods, kits, and compositions for the treatment of pain.

  本发明涉及用于治疗疼痛的方法、试剂盒和组合物。
• ANTIMICROBIAL GEL FORMULATIONS
  申请人：Wang Lu

  公开号：US20100076089A1

  公开（公告）日：2010-03-25

  Disclosed herein are formulations comprising an N-halogenated or N,N-dihalogenated amine compound dispersed in a water-swellable polymer, wherein the compound is 90% stable for at least 30 days at about 25° C. Also disclosed are methods of treating or preventing infections caused by a bacterial, a microbial, a sporal, a fungal or a viral activity using such formulations.

  本文揭示了一种配方，其中包含一种N-卤代或N,N-二卤代胺化合物分散在可水肿胀的聚合物中，其中该化合物在大约25°C下稳定90％，至少30天。还揭示了使用这种配方治疗或预防由细菌、微生物、孢子、真菌或病毒活性引起的感染的方法。
• ANTIMICROBIAL N-HALOGENATED AMINO ACID SALTS
  申请人：Schneider L. Wayne

  公开号：US20090197838A1

  公开（公告）日：2009-08-06

  The present invention relates to a formulation comprising a N-halogenated amino acid and a phase transfer agent. The present invention also describes a method for disinfecting and/or cleaning a contact lens comprising contacting a contact lens with a formulation comprising a N-halogenated amino acid salt for a time sufficient to disinfect and/or clean the lens.

  本发明涉及一种包含N-卤代氨基酸和相转移剂的配方。本发明还描述了一种用于消毒和/或清洁隐形眼镜的方法，包括将隐形眼镜与含N-卤代氨基酸盐的配方接触，以足够的时间消毒和/或清洁镜片。
• N,N-dihalogenated amino acids and derivatives
  申请人：NovaBay Pharmaceuticals, Inc.

  公开号：EP2725008A1

  公开（公告）日：2014-04-30

  The present invention relates to active bactericidal, antibacterial, anti-infective, antimicrobial, sporicidal, disinfectant, antifungal and antiviral compounds and compositions and to new uses of these compositions in therapy. This specification also describes methods of use for the new compounds and compositions. The specification further describes methods for preparing these compounds.

  本发明涉及活性杀菌剂、抗菌剂、抗感染剂、抗菌剂、杀孢子剂、消毒剂、抗真菌剂和抗病毒剂化合物和组合物，以及这些组合物在治疗中的新用途。本说明书还介绍了新化合物和组合物的使用方法。本说明书进一步介绍了制备这些化合物的方法。